Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

5.473 -0.637 (-10.42%)
Streaming Delayed Price Updated: 10:03 AM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bionano Genomics Inc

< Previous 1 2 3 4 5 Next >
MD Anderson Cancer Center Publication Shows How Bionano’s Saphyr System Can Significantly Reduce Time to Actionable Results for Myelodysplastic Syndrome Patients
From GlobeNewswire News Releases
Day Five of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Identifies Structural Variants that May Predispose to Severe COVID-19 Illness
From GlobeNewswire News Releases
Thinking about buying stock in Obseva SA, DBV Technologies, BlackBerry, Five Prime Therapeutics, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for OBSV, DBVT, BB, FPRX, and BNGO. 
From PR Newswire
Day Four of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Solves Genetic Mysteries, Enables Study of Complex Genetic Diseases, Simplifies Muscular Dystrophy Testing
From GlobeNewswire News Releases
Thinking about buying stock in Sundial Growers, FuelCell Energy, Nokia, BioNano Genomics, or Biolase?
InvestorsObserver issues critical PriceWatch Alerts for SNDL, FCEL, NOK, BNGO, and BIOL. 
From PR Newswire
Day Three of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Provides Complete Structural Variation Analysis in Solid Tumors, Enables Discovery of Novel Diagnostic Markers and Drug Targets
From GlobeNewswire News Releases
Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
From GlobeNewswire News Releases
Day Two of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Outperforms Standard Cytogenetics in Heme Malignancies, is Less Expensive, Provides Actionable Information Faster, in Single Assay
From GlobeNewswire News Releases
Bionano Genomics Announces Closing of $101.8 Million Underwritten Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From GlobeNewswire News Releases
Thinking about buying stock in Biolase, Transocean, BP, AMC Entertainment, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for BIOL, RIG, BP, AMC, and BNGO. 
From PR Newswire
Day One of Bionano’s Next-Generation Cytogenomics Symposium: Customer Progress in Applications Development in Prenatal Testing, Validation Against Traditional Cytogenetics and Resolution for Undiagnos
From GlobeNewswire News Releases
Thinking about buying stock in Nio, Zomedica, Transenterix, Aileron Therapeutics, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for NIO, ZOM, TRXC, ALRN, and BNGO. 
From PR Newswire
COVID-19 Host Genome SV Consortium Identifies Structural Variants with Possible Roles in Pathogenesis and Outcomes in Severely Ill COVID-19 Patients Using Bionano’s Saphyr® System
First publication from international consortium highlights prowess of Saphyr in identifying large SVs with clinical significance and in COVID-19, an area with great public health implications 
From GlobeNewswire News Releases
Bionano Genomics Announces the Kick-Off of its Next-Generation Cytogenomics Symposium, The Largest Event Yet to Showcase Saphyr’s Utility in Genome Analysis for Genetic Disease and Cancer
From GlobeNewswire News Releases
Bionano Genomics Announces Pricing of $88.5 Million Underwritten Public Offering of Common Stock
From GlobeNewswire News Releases
Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock
From GlobeNewswire News Releases
Thinking about buying stock in Sundial Growers, Zomedica, BioNano Genomics, IsoRay, or Jaguar Health?
InvestorsObserver issues critical PriceWatch Alerts for SNDL, ZOM, BNGO, ISR, and JAGX. 
From PR Newswire
Thinking about buying stock in Sundial Growers, BioNano Genomics, Zomedica, Jaguar Health, or Onconova Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for SNDL, BNGO, ZOM, JAGX, and ONTX. 
From PR Newswire
Small Cap Momentum Stocks on the Radar (NASDAQ: BNGO) (OTC US: MMEDF) (OTC US: LVGI) (OTC US: HVBTF)
Tags Media OTC PR WIRE Stock Report
From OTC
Thinking about buying stock in BioNano Genomics, Ocugen, Acasti Pharma, Novan, or Transenterix?
InvestorsObserver issues critical PriceWatch Alerts for BNGO, OCGN, ACST, NOVN, and TRXC. 
From PR Newswire
Thinking about buying stock in Ocugen, BioNano Genomics, FLIR Systems, Clearside Biomedical, or Viewray?
InvestorsObserver issues critical PriceWatch Alerts for OCGN, BNGO, FLIR, CLSD, and VRAY. 
From PR Newswire
Bionano Genomics Publishes Study on Autism Risk Genes After Detailed Analysis of The Genome of Professor Temple Grandin, Who Has Brought Awareness to Autism Spectrum Disorder Through Her Activism
From GlobeNewswire News Releases
Thinking about buying stock in BioNano Genomics, Ampio Pharmaceuticals, TRACON Pharmaceuticals, eMagin Corp, or Matinas BioPharma?
InvestorsObserver issues critical PriceWatch Alerts for BNGO, AMPE, TCON, EMAN, and MTNB. 
From PR Newswire
Thinking about buying stock in Hepion Pharmaceuticals, BioNano Genomics, T2 Biosystems, Surface Oncology, or Sesen Bio?
InvestorsObserver issues critical PriceWatch Alerts for HEPA, BNGO, TTOO, SURF, and SESN. 
From PR Newswire
Bionano Genomics Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
From GlobeNewswire News Releases
Thinking about buying stock in BioNano Genomics, Ocugen Inc, Biolase, Gevo, or FuelCell Energy?
InvestorsObserver issues critical PriceWatch Alerts for BNGO, OCGN, BIOL, GEVO, and FCEL. 
From PR Newswire
Thinking about buying stock in Zomedica, Jaguar Health, BioNano Genomics, Biolase, or Delta Air Lines?
InvestorsObserver issues critical PriceWatch Alerts for ZOM, JAGX, BNGO, BIOL, and DAL. 
From PR Newswire
Bionano Customer Praxis Genomics Accredited by College of American Pathologists, Completing First LDT in US for Constitutional Genetic Disorders that Uses Whole Genome Analysis with Saphyr as Alternat
From GlobeNewswire News Releases
Publication Reveals in Side-by-Side Comparison that Method Using PacBio Sequencing Detects Only 72% of the Large Structural Variants Detected by Optical Genome Mapping with Saphyr
From GlobeNewswire News Releases
Bionano Genomics Achieves Key Milestone with Software Update for its Saphyr System that Increases Throughput to 96 Human Genomes Per Week and Adds Saphyr Assure for Monitoring System Health
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.